THESEUS PHARMACEUTICALS, INC. Deferred Tax Assets, Net of Valuation Allowance
THESEUS PHARMACEUTICALS, INC. had Deferred Tax Assets, Net of Valuation Allowance of $25.52 million as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-03-09
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $25.52M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $11.52M.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.26M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2022-12-31 | $25.52M 10-K · filed 2023-03-09 |
| 2021-12-31 | $11.52M 10-K · filed 2023-03-09 |
| 2020-12-31 | $4.26M 10-K · filed 2022-03-10 |